The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial
| Image |  |
|---|---|
| Description | scientific article published on 10 October 2019 |
| Author/s |
author: Marcel H.A. Muskiet Daniel H van Raalte Erik J M van Bommel Mark H H Kramer Mark M Smits |
| Publication date | October 10, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |